16 results
8-K
EX-3.2
RNAC
Cartesian Therapeutics Inc
28 Mar 24
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split
5:00pm
8-K
EX-3.1
RNAC
Cartesian Therapeutics Inc
28 Mar 24
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split
5:00pm
10-Q
2023 Q3
EX-3.2
RNAC
Cartesian Therapeutics Inc
Quarterly report
13 Nov 23
4:31pm
8-K
EX-3.3
RNAC
Cartesian Therapeutics Inc
13 Nov 23
Entry into a Material Definitive Agreement
9:02am
8-K
EX-3.4
RNAC
Cartesian Therapeutics Inc
13 Nov 23
Entry into a Material Definitive Agreement
9:02am
8-K
EX-3.2
l439och
22 Aug 22
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
EX-3.1
s2zpwqli3 9bxk
21 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
EX-3.2
1h5zvxjizoo 0yco55i
30 Sep 21
Amendments to Articles of Incorporation or Bylaws
8:00am
8-K
EX-3.2
dqi9 4exlhd5
29 Jun 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
5n4iveg
29 Jun 16
Amendments to Articles of Incorporation or Bylaws
12:00am
S-1/A
EX-3.1
7nk3v0dp8g6ver1ej
8 Jun 16
IPO registration (amended)
12:00am
S-1
EX-3.2
nn9lsa1aghp6lh8kuqwz
24 May 16
IPO registration
12:00am
S-1
EX-3.4
5n5wdjkaesqfifc
24 May 16
IPO registration
12:00am
S-1
EX-3.3
bt7bcn zc
24 May 16
IPO registration
12:00am
DRS
EX-3.2
mjvno8v zyuo54z
24 Nov 15
Draft registration statement
12:00am
DRS
EX-3.1
v2odzcj
24 Nov 15
Draft registration statement
12:00am
- Prev
- 1
- Next